Joe Smith

Joe Smith has more than 40 years of business and legal experience. Most recently he was Senior Vice President, Business Development and General Counsel of Cepheid, a leading developer of integrated systems for genetic assessment. Continue reading

Floyd E. Romesberg, Ph.D.

Floyd E. Romesberg, Ph.D., is currently a Sanofi scholar at Synthorx, a Sanofi company, where his group works to use the expanded genetic alphabet/code to create novel therapeutics. Romesberg co-founded three biotech companies, Achaogen, RQx Pharmaceutics, and Synthorx.
Continue reading

Richard T. Pomerantz, Ph.D.

Richard T. Pomerantz, Ph.D., is currently an associate professor in the Department of Biochemistry and Molecular Biology and principal investigator at the Sidney Kimmel Cancer Center at Thomas Jefferson University, where he studies mechanisms of DNA replication and repair and develops cancer therapeutics and DNA/RNA biotechnologies. Continue reading